This gene panel generates an in-depth report based on the whole-exome DNA and RNA profiling by leveraging AI and machine learning algorithms. This report includes the Cellworks proprietary Therapy Response Index (TRI) and Pathway Analysis.

This comprehensive approach identifies true somatic mutations and enables parallel tissue DNA/RNA and ctDNA analysis. As a result, it facilitates optimal disease resolution and improves clinical decision-making.

By combining the insights from comprehensive genomic analysis and therapy prediction, this gene panel empowers oncologists to personalize cancer treatment plans. The information provided in the report helps guide clinicians in selecting the most appropriate therapies and combinations tailored to each patient’s unique genomic profile.

Enhances treatment decision-making and facilitates targeted therapy selection that leads to improved treatment efficacy, reduced adverse effects, and better patient outcomes.

Our Cancer Gene Panel thoroughly assesses clinically relevant genes, ensuring accurate and reliable results.

We utilize cutting-edge next generation sequencing technology to deliver precise and detailed genetic information.

Our team of experienced genetic counselors and healthcare professionals will guide you through the testing process, answer your questions, and help you understand the implications of the results.

We adhere to strict privacy protocols and maintain the confidentiality of your genetic information.